These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1950287)

  • 1. [The validation of the expediency of a review of the times for revaccinating children against measles].
    Rusakova EV; Bezuglova MS; Vasil'eva VI; Frank KD; Drynov ID; Filatov NN; Demskiĭ VI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Aug; (8):51-4. PubMed ID: 1950287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of the selective revaccination of schoolchildren against measles].
    Fel'dman EV; Kapustik LA; Belous TI; Bir'iak VN; Kuznetsova NK
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):30-4. PubMed ID: 2930972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intranasal revaccination of children with live measles vaccine: development of local immunity].
    Liashenko VA; Iuminova NV; Krasnova VP; Glazkova NV; Svirina VS
    Vopr Virusol; 1999; 44(3):124-6. PubMed ID: 10392436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Revaccination of children inoculated against measles].
    Bolotovskiĭ VM; Titova NS; Bakhur EA; Tamm OM; Miartin IaK
    Pediatriia; 1981 Dec; (12):46-8. PubMed ID: 7335425
    [No Abstract]   [Full Text] [Related]  

  • 5. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes.
    Dilraj A; Cutts FT; Bennett JV; Fernandez de Castro J; Cohen B; Coovadia HM
    Pediatr Infect Dis J; 2000 Dec; 19(12):1211-3. PubMed ID: 11144388
    [No Abstract]   [Full Text] [Related]  

  • 7. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of measles revaccination among school-entry-aged children.
    Watson JC; Pearson JA; Markowitz LE; Baughman AL; Erdman DD; Bellini WJ; Baron RC; Fleming DW
    Pediatrics; 1996 May; 97(5):613-8. PubMed ID: 8628596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of computers and mathematical methods for optimizing epidemic control measures with respect to measles infection].
    Bezuglova MS; Rusakova EV; Frank KD; Drynov ID; Vasil'eva VI; Filatov NN; Mironova VF
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):44-7. PubMed ID: 1759519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles seroepidemiology among adolescents and young adults: response to revaccination.
    Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
    East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The results of multiyear observations on the duration of the maintenance of immunity in those vaccinated and revaccinated against and recovered from measles].
    Sliusar' LI; Sokhin AA; Radomskaia FS; Degtiareva GV; Panasenko LI; Litvinova TP; Komarevskaia RV; Bol'shinskaia ZhI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):66-70. PubMed ID: 2239007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinico-laboratory and seroepidemiological examinations of children immunized with live measles vaccine prepared from genetically homogeneous strain Moscow-5].
    Unanov SS; Iuminova NV; Pasechnik AL; Sokolova AF; Gordienko NM
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):49-54. PubMed ID: 4072497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 14. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sero-epidemiology of measles in children from Eastern Turkey.
    Altinkaynak S; Ertekin V; Güraksin A; Kiliç A; Yiğit N
    West Indian Med J; 2005 Sep; 54(4):236-7. PubMed ID: 16312189
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the persistence of immunity 15 years after revaccination with measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):392-5. PubMed ID: 2598096
    [No Abstract]   [Full Text] [Related]  

  • 18. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Means of improving measles vaccinal prophylaxis].
    Smorodintsev AA; Boĭchuk LM; Rykushin IuP; Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():12-9. PubMed ID: 162456
    [No Abstract]   [Full Text] [Related]  

  • 20. [The duration and strength of postvaccinal measles immunity].
    Bolotovskiĭ VM; Gelikman BG; Auzinia AV; Glinskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):32-7. PubMed ID: 2386001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.